Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.

Géraldine DescampsYasemin KaracaJérôme R LechienNadège KindtChristine DecaesteckerMyriam RemmelinkDenis LarsimontGuy AndrySamantha HassidAlexandra RodriguezMohammad KhalifeFabrice JourneSven Saussez

Published in: Journal of cancer research and clinical oncology (2016)

The risk of death from HNSCC significantly increases when patients are exposed to tobacco and alcohol during their therapy, regardless of HPV status.

Keyphrases

end stage renal disease
risk factors
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
high grade
stem cells
squamous cell carcinoma
radiation therapy
locally advanced